Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more) Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more) Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Corcept Therapeutics Inc CORT

Healthcare
Corcept Therapeutics Incorporated is a commercial-stage company, which is engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has... see more

Recent & Breaking News (NDAQ:CORT)

Corcept Therapeutics Announces First Quarter 2016 Financial Results and Provides Corporate Update

Marketwired May 3, 2016

Corcept Therapeutics to Announce First Quarter Financial Results and Corporate Update and Host Conference Call

Marketwired April 29, 2016

Promising Pre-Clinical and Phase 1 Data Support Advance of Selective Cortisol Modulator CORT125134 as Potential Treatment for Cushing's Syndrome and Solid-Tumor Cancers

Marketwired April 28, 2016

Corcept Therapeutics Announces 2015 Financial Results

Marketwired March 1, 2016

Corcept Therapeutics Announces Preliminary Fourth Quarter and Full Year 2015 Summary Financial Results, Provides 2016 Revenue Guidance and Corporate Update

Marketwired January 28, 2016

Corcept Therapeutics to Announce Preliminary 2015 Financial Results, Provide 2016 Revenue Guidance and Corporate Update, and Host Conference Call

Marketwired January 21, 2016

Perception, Opportunity in Volatility - Featured Research on Corcept Therapeutics, Pioneer Energy Services, Ruby Tuesday, and RealD

Accesswire December 15, 2015

Corcept Therapeutics Announces Initial Efficacy Results in Phase 1/2 Trial of Mifepristone in Combination With Eribulin for the Treatment of Patients With Metastatic Triple-Negative Breast Cancer

Marketwired December 14, 2015

Market Data on Movers and Shakers- Research on Cardiovascular Systems, Sportsman's Warehouse Holdings, Ardelyx and Corcept Therapeutics

Accesswire November 19, 2015

Stocks under Technical Scanner - Research on Quad/Graphics, American Residential Properties, Chuy's Holdings and Corcept Therapeutics

Accesswire November 9, 2015

Corcept Therapeutics Announces Third Quarter 2015 Results and Provides Corporate Update

Marketwired November 5, 2015

Biotech Bonanza: 4 Stocks With Pending Clinical or Preclinical News (And Why the Results Will Move the Stocks)

Accesswire November 2, 2015

Corcept Therapeutics to Announce Third Quarter Financial Results and Corporate Update and Host Conference Call

Marketwired October 29, 2015

Results of Phase 1 Trial of Next-Generation Cortisol Modulator CORT125134 to Be Presented at Annual Meeting of the American Association of Pharmaceutical Scientists

Marketwired October 13, 2015

Corcept Therapeutics Appoints Robert S. Fishman, M.D., as Chief Medical Officer

Marketwired September 28, 2015

Corcept Therapeutics Announces Second Quarter 2015 Results and Provides Corporate Update

Marketwired August 5, 2015

Corcept Therapeutics to Announce Second Quarter Financial Results and Corporate Update and Host Conference Call

Marketwired July 29, 2015

Corcept Therapeutics Appoints Daniel Swisher to Board of Directors

Marketwired June 22, 2015

Corcept Therapeutics Announces Poster Presentations on Mifepristone for the Treatment of Patients With Cushing's Syndrome at the 27th Annual American Association of Clinical Endocrinologists

Marketwired May 14, 2015

Corcept Therapeutics' Mifepristone Combined With Eribulin to Improve Antitumor Activity in Patients With Triple-Negative Breast Cancer

Marketwired May 13, 2015